Esketamine as Treatment for Chronic Pain Due to Endometriosis: a RCT Study
Status:
Recruiting
Trial end date:
2025-06-06
Target enrollment:
Participant gender:
Summary
The goal of this randomized controlled trial is to investigate the effect of esketamine
versus placebo on the NRS score for chronic pelvic pain. Secondary endpoints are to assess
pain scores, side-effects, quality of life, depressive symptoms and pain coping.